Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine

Recall Type: Drug Recall

Source: FDA Recall Notice

Recall Date: July 18, 2026

Summary: FOR IMMEDIATE RELEASE – July 18th, 2026 – Panoli, Gujarat, Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is voluntarily recalling four lots of Cetirizine Hydrochloride Tablets USP 5 mg to the consumer level due to cross contamination with Ranitidine.

Read the original recall notice

Medication Ingredient Resources

Need to check medication ingredients or possible allergen concerns? Visit PillParser.com for ingredient lookup and RxAllergyScan.com to compare medications against an allergen profile.

← Back to Recalls